<?xml version="1.0" encoding="UTF-8"?>
<ref id="B5-microorganisms-08-00196">
 <label>5.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Nosyk</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Min</surname>
    <given-names>J.E.</given-names>
   </name>
   <name>
    <surname>Lima</surname>
    <given-names>V.D.</given-names>
   </name>
   <name>
    <surname>Hogg</surname>
    <given-names>R.S.</given-names>
   </name>
   <name>
    <surname>Montaner</surname>
    <given-names>J.S.</given-names>
   </name>
   <collab>SHAs Group</collab>
  </person-group>
  <article-title>Cost-effectiveness of population-level expansion of highly active antiretroviral treatment for HIV in British Columbia, Canada: A modelling study</article-title>
  <source>Lancet HIV</source>
  <year>2015</year>
  <volume>2</volume>
  <fpage>e393</fpage>
  <lpage>e400</lpage>
  <pub-id pub-id-type="doi">10.1016/S2352-3018(15)00127-7</pub-id>
  <pub-id pub-id-type="pmid">26423553</pub-id>
 </element-citation>
</ref>
